it started publishing its first journal in 2008 by 2015 it claimed over 700 journals although about half of them were defunct its subsidiaries include imedpub ltd and conference series llc ltd other organisations linked to omics are euroscicon ltd allied academies trade science inc and meetings international omics has come under attack by numerous academics and the united states government over the validity of the peer review by omics journals the appropriateness of its fees and marketing and the apparent advertising of the names of scientists as journal editors or conference speakers without their knowledge or permission the u s national institutes of health sent a cease and desist letter to omics in 2013 demanding it to discontinue with false claims of affiliation with u s government entities or employees in august 2016 omics became the first academic publisher to be sued by the u s federal trade commission ftc for deceptive practices nearly three years later the ftc was awarded a summary judgement of over us 50 million omics has responded to criticisms by avowing a commitment to open access publishing claiming that detractors are traditional subscription based publishers who feel threatened by their open access publishing model